GlassScriptPhysician profile
Parth P Patel
NPI 1023547601
$4,268.44
in general payments reported to CMS, 2019-2025
32 companies · $2,028 in 2025
The $2,028 reported for 2025 was more than what 88% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.48 · 2023: $569 · 2024: $1,656 · 2025: $2,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,252.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $664.67 | 2023-2025 | Opzelura |
| Lilly USA, LLC | $478.52 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Ucb, INC. | $414.46 | 2023-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $394.32 | 2023-2025 | |
| Organogenesis INC. | $293.65 | 2024-2025 | Simplimax, Novachor, Via Matrix |
| Abbott Laboratories | $234.45 | 2024-2025 | Freestyle Libre 3, Coroflow |
| Amgen INC. | $214.34 | 2023-2025 | Otezla, Otezla |
| Genzyme Corporation | $159.50 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $137.63 | 2023-2025 | Winlevi, Odomzo, Blu-U |
| Regeneron Healthcare Solutions, INC. | $136.46 | 2024-2025 | Dupixent, Libtayo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $118.94 | 2024-2025 | Cabtreo |
| Galderma Laboratories, L.P. | $110.38 | 2024-2025 | Nemluvio |
| Janssen Biotech, INC. | $103.41 | 2022-2024 | Tremfya |
| Novartis Pharmaceuticals Corporation | $81.36 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $80.01 | 2023-2025 | Sotyktu |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $67.98 | 2024-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Arcutis Biotherapeutics, INC. | $62.10 | 2025 | Zoryve |
| Medtronic, INC. | $58.85 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Organon LLC | $57.91 | 2025 | Vtama |
| Leo Pharma INC. | $52.08 | 2024-2025 | Adbry |
| Kerecis Limited | $52.05 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.28 | 2024 | Spevigo |
| Pfizer INC. | $44.45 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $42.52 | 2023-2025 | |
| Medshape, INC. | $26.56 | 2023 | Dynanail Helix, Washer, 15 Mm |
| Averitas Pharma INC. | $22.11 | 2024 | Qutenza |
| Krystal Biotech INC | $21.47 | 2023 | Vyjuvek |
| Paratek Pharmaceuticals, INC. | $20.17 | 2025 | Nuzyra |
| Mallinckrodt Hospital Products INC. | $19.91 | 2024 | Acthar |
| Convatec INC. | $18.25 | 2024 | |
| Journey Medical Corporation | $17.08 | 2023 | |
| Genentech USA, INC. | $13.57 | 2023 | Xolair |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.